Skip to content
← Back to this collection

PUBLICATIONS · 23491275

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2013 Apr
First author
Galimberti V

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2013 Jun;14(7):e254
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    Lancet Oncol. 2013 Apr;14(4):266-7. doi: 10.1016/S1470-2045(13)70074-3.
    note
    Source null
    related pmid
    23491276
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2013 Jun;14(7):e250. doi: 10.1016/S1470-2045(13)70195-5.
    note
    Source null
    related pmid
    23725703
    relationship
    Comment in
  4. citation
    Lancet Oncol. 2013 Jun;14(7):e250-1. doi: 10.1016/S1470-2045(13)70218-3.
    note
    Source null
    related pmid
    23725704
    relationship
    Comment in
  5. citation
    Lancet Oncol. 2013 Jun;14(7):e251-2. doi: 10.1016/S1470-2045(13)70241-9.
    note
    Source null
    related pmid
    23725705
    relationship
    Comment in

Authors and identifiers

  1. name
    Galimberti V
    type
    Author
  2. name
    Cole BF
    type
    Author
  3. name
    Zurrida S
    type
    Author
  4. name
    Viale G
    type
    Author
  5. name
    Luini A
    type
    Author
  6. name
    Veronesi P
    type
    Author
  7. name
    Baratella P
    type
    Author
  8. name
    Chifu C
    type
    Author
  9. name
    Sargenti M
    type
    Author
  10. name
    Intra M
    type
    Author
  11. name
    Gentilini O
    type
    Author
  12. name
    Mastropasqua MG
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Galimberti V
    type
    Author
  2. name
    Cole BF
    type
    Author
  3. name
    Zurrida S
    type
    Author
  4. name
    Viale G
    type
    Author
  5. name
    Luini A
    type
    Author
  6. name
    Veronesi P
    type
    Author
  7. name
    Baratella P
    type
    Author
  8. name
    Chifu C
    type
    Author
  9. name
    Sargenti M
    type
    Author
  10. name
    Intra M
    type
    Author
  11. name
    Gentilini O
    type
    Author
  12. name
    Mastropasqua MG
    type
    Author
bibliography ids
  1. nci-bib-c94e07fd2c735738d33ebd08
book metadata
content sha256
007ad61ce22eb817836657db35f41a340f706fd90bb21dca97b69bbba040e05b
document type
citation
dois
  1. 10.1016/S1470-2045(13)70035-4
electronic publication date
display
2013 Mar 11
precision
day
year
2013
evidence scope
bibliographic_metadata_only
id
pubmed:23491275
immutable id
pubmed:23491275@007ad61ce22eb817836657db35f41a340f706fd90bb21dca97b69bbba040e05b
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
4
name
The Lancet. Oncology
nlm unique id
100957246
pages
297-305
volume
14
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2013 Jun;14(7):e254
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    Lancet Oncol. 2013 Apr;14(4):266-7. doi: 10.1016/S1470-2045(13)70074-3.
    note
    Source null
    related pmid
    23491276
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2013 Jun;14(7):e250. doi: 10.1016/S1470-2045(13)70195-5.
    note
    Source null
    related pmid
    23725703
    relationship
    Comment in
  4. citation
    Lancet Oncol. 2013 Jun;14(7):e250-1. doi: 10.1016/S1470-2045(13)70218-3.
    note
    Source null
    related pmid
    23725704
    relationship
    Comment in
  5. citation
    Lancet Oncol. 2013 Jun;14(7):e251-2. doi: 10.1016/S1470-2045(13)70241-9.
    note
    Source null
    related pmid
    23725705
    relationship
    Comment in
outcomes validated
false
pmid
23491275
provenance
batch id
99e008dabc339d38fd44
provider
NCBI PubMed ESummary
record sha256
776b1780f6303a0482138063d38a99e40c15fdd758066dadbdf393e5bad1ec69
response sha256
804916232567480946eda9a00aff276bc44fd9a6d15d9336e773a9c803123d39
retrieved at
2026-09-09T23:46:55.094762+00:00
publication date
display
2013 Apr
precision
month
year
2013
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, N.I.H., Extramural
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/23491275/
title
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.

Preserved source evidence · Not medical advice